Hypogonadism As a Consequence of Craniopharyngioma in Female Patients: Comparison of Childhood and Adult Onset and Effects of Estrogen Replacement Therapy

Overview

Journal Endocrine

Specialty Endocrinology

Date 2024 May 18

PMID 38761348

Authors

Irena Ilovayskaya

Vita Zektser

Affiliations

Soon will be listed here.

Abstract

Purpose: (1) to compare clinical, biochemical features in female patients with hypoestrogenism due to childhood- and adult-onset CP; (2) to reveal effects of estrogen replacement therapy in female patients with childhood-onset CP.

Methods: Thirty-seven women that received specific treatment for CP in the period from 1980 to 2019 were recruited: 21 with childhood-onset and 16 with adult-onset CP. Clinical and hormonal characteristics were evaluated. Seventeen-beta-estradiol 2 mg and dydrogesterone 10 mg in sequential regiment was used in 18 childhood-onset cases. Mean follow-up was 31 months.

Results: Amenorrheic women with childhood- and adult-onset CP presented with the same complaints except for lack of genital hair and breast hypoplasia, which were common in patients with childhood-onset CP. BMI was lower in childhood-onset CP group, as was the proportion of overweight patients. They had more favorable lipid profile. The levels of estradiol, testosterone and DHEA-S were low and did not differ. Uterine and ovary volumes were reduced in all patients, but the decline was noticeable in the childhood-onset group. Mineral bone density of lumbar vertebrae was diminished in childhood-onset group. Estrogen therapy in these patients led to clinical improvement: increase in BMD in lumbar spine without negative changes in BMI and/or lipid profile.

Conclusions: Study showed that women with childhood-onset CP had less negative metabolic changes. However, they have more pronounced breast and uterus hypoplasia and lower BMD in lumbar spine. The estrogen replacement therapy led to clinical improvement and BMD increase in lumbar spine without increase of BMI and/or lipid profile changes.

References

Louis D, Perry A, Wesseling P, Brat D, Cree I, Figarella-Branger D . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021; 23(8):1231-1251. PMC: 8328013. DOI: 10.1093/neuonc/noab106. View

Diaz M, Kwak S, Root K, Fadil A, Nguyen A, Ladehoff L . Current Approaches to Craniopharyngioma Management. Front Biosci (Landmark Ed). 2023; 27(12):328. DOI: 10.31083/j.fbl2712328. View

Erfurth E . Endocrine aspects and sequel in patients with craniopharyngioma. J Pediatr Endocrinol Metab. 2014; 28(1-2):19-26. DOI: 10.1515/jpem-2014-0419. View

Sterkenburg A, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbuchel A, Muller H . Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro Oncol. 2015; 17(7):1029-38. PMC: 5654354. DOI: 10.1093/neuonc/nov044. View

Ahmed B, Merz C, Johnson B, Bittner V, Berga S, Braunstein G . Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study). Am J Cardiol. 2008; 102(2):150-4. PMC: 3615899. DOI: 10.1016/j.amjcard.2008.03.029. View

Merz C, Johnson B, Sharaf B, Bittner V, Berga S, Braunstein G . Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol. 2003; 41(3):413-9. DOI: 10.1016/s0735-1097(02)02763-8. View

Tritos N, Greenspan S, King D, Hamrahian A, Cook D, Jonsson P . Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis. J Clin Endocrinol Metab. 2011; 96(5):1516-23. PMC: 5393425. DOI: 10.1210/jc.2010-2662. View

Holmer H, Popovic V, Ekman B, Follin C, Siversson A, Erfurth E . Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma. Eur J Endocrinol. 2011; 165(1):25-31. DOI: 10.1530/EJE-11-0229. View

Matthews D, Bath L, Hogler W, Mason A, Smyth A, Skae M . Hormone supplementation for pubertal induction in girls. Arch Dis Child. 2017; 102(10):975-980. DOI: 10.1136/archdischild-2016-311372. View

10.

Miller K, Sesmilo G, Schiller A, Schoenfeld D, Burton S, Klibanski A . Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab. 2001; 86(2):561-7. DOI: 10.1210/jcem.86.2.7246. View

11.

Olivius C, Landin-Wilhelmsen K, Olsson D, Johannsson G, Tivesten A . Prevalence and treatment of central hypogonadism and hypoandrogenism in women with hypopituitarism. Pituitary. 2018; 21(5):445-453. DOI: 10.1007/s11102-018-0895-1. View

12.

Pluchino N, Carmignani A, Cubeddu A, Santoro A, Cela V, Errasti T . Androgen therapy in women: for whom and when. Arch Gynecol Obstet. 2013; 288(4):731-7. DOI: 10.1007/s00404-013-2969-7. View

13.

Miller K, Biller B, Beauregard C, Lipman J, Jones J, Schoenfeld D . Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2006; 91(5):1683-90. DOI: 10.1210/jc.2005-2596. View

14.

Zang H, Davis S . Androgen replacement therapy in androgen-deficient women with hypopituitarism. Drugs. 2008; 68(15):2085-93. DOI: 10.2165/00003495-200868150-00001. View

15.

Okinaga H, Matsuno A, Okazaki R . High risk of osteopenia and bone derangement in postsurgical patients with craniopharyngiomas, pituitary adenomas and other parasellar lesions. Endocr J. 2006; 52(6):751-6. DOI: 10.1507/endocrj.52.751. View

16.

Tritos N, Hamrahian A, King D, Greenspan S, Cook D, Jonsson P . A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis. Eur J Endocrinol. 2012; 167(3):343-51. PMC: 4890184. DOI: 10.1530/EJE-12-0070. View

17.

Hage M, Plesa O, Lemaire I, Raffin Sanson M . Estrogen and Progesterone Therapy and Meningiomas. Endocrinology. 2021; 163(2). DOI: 10.1210/endocr/bqab259. View

18.

Martinez-Ortega A, Flores-Martinez A, Venegas-Moreno E, Dios E, Del Can D, Rivas E . Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics. J Clin Med. 2022; 11(1). PMC: 8746083. DOI: 10.3390/jcm11010281. View

19.

Fleseriu M, Hashim I, Karavitaki N, Melmed S, Murad M, Salvatori R . Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101(11):3888-3921. DOI: 10.1210/jc.2016-2118. View

20.

Mah P, Webster J, Jonsson P, Feldt-Rasmussen U, Koltowska-Haggstrom M, Ross R . Estrogen replacement in women of fertile years with hypopituitarism. J Clin Endocrinol Metab. 2005; 90(11):5964-9. DOI: 10.1210/jc.2005-1207. View